Physician profile
Roy Mutia Lim, JR.
NPI 1518549336
$1,512.92
in general payments reported to CMS, 2019-2025
12 companies · $1,274 in 2025
The $1,274 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.37 · 2024: $218 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.13 |
| Education | $326.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $517.79 | 2024-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.53 | 2024-2025 | Lifevest |
| Pfizer INC. | $209.29 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $166.76 | 2024-2025 | Farxiga, Lokelma, Calquence |
| Novartis Pharmaceuticals Corporation | $85.53 | 2025 | |
| Scpharmaceuticals INC. | $76.42 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $67.20 | 2025 | |
| Impulse Dynamics (USA) INC. | $58.39 | 2025 | Optimizer |
| Medtronic, INC. | $51.76 | 2025 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals International, Plc | $26.62 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $22.26 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $20.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.